Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.72 USD | -1.44% | -10.31% | +165.59% |
May. 10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
May. 09 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Analyst Reco.